Mr. Nuno Cardoso
President | Associação de Distribuidores Farmacêuticos (ADIFA)
Nuno Cardoso graduated from the Faculty of Pharmacy, University of Lisbon in 2013 with an Integrated Masters in Pharmaceutical Sciences. His master’s thesis was entitled “Analyzing the Pharmaceutical Sector: Economical and political context and the future of reimbursement systems”. Still in college, he underwent extra-curricular training in pharmaceutical marketing and regulatory affairs.
During his education he was involved in students’ associations. He was elected President of the Executive Board of the Students Association of the University of Lisbon Faculty of Pharmacy, and later elected General Assembly’s President. Nuno was also a member of the Senate of the University of Lisbon between 2011-2013 and General Counsellor to the Academic Association at the same University.
In 2015 he concluded the Post-Graduation on Management for Pharmacists at the Católica Lisbon School of Business and Economics. As a pharmacist, Nuno held the position of Technical Secretary of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society between January 2014 and July 2017. Between April 2017 and March 2020, he practiced as Secretary-General of the Portuguese Full-Service Pharmaceutical
Distributors Association (ADIFA).In 2018 Nuno joined the Legal Affairs Committee of the European Healthcare Distribution Association (GIRP) and the Pharmaceutical Distribution’ Professional Group of the Portuguese Pharmaceutical Society (until 2019).
Since 2019, he is a Board Member of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Board Member of the Alumni Association of the Faculty of Pharmacy, and member of the Public Affairs and Policy Committee of GIRP. During 2019, Nuno also collaborated with the International Pharmaceutical Federation (FIP) on the establishment of a FIP Expert Group on Supply Chain.
In 2019 he concluded the Negotiation Specializations Program at the Católica Lisbon School of Business and Economics.
Since March 2020 he is President of the Portuguese Full-Service Pharmaceutical Distributors Association (ADIFA). Board Member of VALORMED – Sociedade Gestora de Resíduos de Embalagens de Medicamentos, LDA. since March 2020 and Board Member of Dignitude Association since November 2020.
Nuno has participated in the development of national and internationally awarded projects, such as the Healthy Generation Project (Portuguese Pharmaceutical Awards 2014, category “Project of the Year”), the awareness campaign “Use of Medicines – We are all responsible” (Portuguese Pharmaceutical Awards 2015, category “Project of the Year” and the FIP 2016 Health Promotion Campaign Award), was co-author of the scientific poster “Bringing Health Promotion and Education to Schools – impact and evaluation of the Healthy Generation Project”, which was selected to oral presentation at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, and coauthor of the article “A media campaign in Portugal to highlight responsible medicines use” published in The Pharmaceutical Journal.
Mr. Steve Collis
Chief Executive Officer | AmeriSourceBergen
Steven H. Collis is Chairman, President and CEO of AmerisourceBergen Corporation, a global healthcare solutions leader, currently ranked No.10 on the Fortune 500. He was elected president and CEO in 2011 and chairman in 2016. Under Mr. Collis’ leadership, AmerisourceBergen has experienced tremendous financial growth. The company’s annual revenue has jumped more than 80% during Mr. Collis’ tenure as CEO and its number of employees has risen to 21,000, with offices in more than 50 countries worldwide.
Through strategic investments and acquisitions, the company has expanded its breadth of services and solutions resulting in unprecedented customer partnerships, global reach and deep expertise that is shaping healthcare delivery. Specifically, AmerisourceBergen’s agreement with Walgreens Boots Alliance in 2013 marked an industry first—with a national pharmacy chain turning over all its pharmaceutical distribution to a wholesaler and collaborating on a global basis for generic product sourcing. The company’s 2015 acquisition of MWI Veterinary Supply further reflect AmerisourceBergen’s ability to deliver value in diverse aspects of patient care and growing markets. As a result, the Wall Street Journal named Mr. Collis as the best performing chief executive in the Philadelphia region for 2015, and Barron’s ranked AmerisourceBergen two years in a row as No. 1 on their list of the 500 top performing companies.
Mr. Collis has additionally forged a clear path in fulfilling AmerisourceBergen’s purpose of being united in our responsibility to create healthier futures. He spearheaded the creation of the AmerisourceBergen Foundation, the company’s first enterprise-wide, nonprofit charitable organization, which supports health-related causes that enrich the global community. Under his leadership, the company’s commitment to diversity and inclusion continue to be recognized, with AmerisourceBergen being named a DiversityInc Noteworthy Company in 2017, 2018 and 2019. The company was also honored by the Women's Forum of New York as a leading company for gender balance on its board of directors.
Mr. Collis’ career with AmerisourceBergen spans more than two decades and includes time leading the company’s specialty and wholesale distribution and related services businesses. He helped found the former Specialty Group business in 1994 and grew it into the market leader in specialty pharmaceutical distribution and product commercialization services.
Mr. Collis earned a Bachelor of Commerce with Honors degree from the University of Witwatersrand in Johannesburg, South Africa. In addition to serving as chairman of AmerisourceBergen’s board of directors, he serves on the board of the International Federation of Pharmaceutical Wholesalers. Mr. Collis is a founding vice chairman of the American Cancer Society’s CEOs Against Cancer Pennsylvania chapter and serves on the Board of Governors for the American Red Cross.
Ms. Monika Derecque-Pois
Director General | European Healthcare Distribution Association (GIRP)
Monika Derecque-Pois was born in Graz/Austria and holds a master’s degree in Economics from the University of Economics in Vienna, where she specialised in International Trade and Marketing.
Ms. Monika Derecque-Pois is the Director General of GIRP, the European Healthcare Distribution Association, which brings together over 750 pharmaceutical full-line wholesaling companies and their national associations from 35 countries. Monika was appointed to her current position in 2001, having previously served as European affairs consultant for GIRP. She has over 20 years of experience in European public affairs.
Prior to her engagement with GIRP, she served as a director in a European affairs consultancy company and she also held a six-year post as Marketing and Client Support Manager at IMS Health Austria.
Mr. Martin FitzGerald
Deputy Director General | European Healthcare Distribution Association (GIRP)
Martin is the Deputy Director General for the European Healthcare Distribution Association (GIRP). Martin advises the Association on the matrix of legal issues impacting upon the interests of the pharmaceutical full-line wholesale sector in Europe. He also represents the association externally and in this respect works with the European institutions such as the European Commission, the European Parliament and the Council as well as with other European and international organisations such as the Council of Europe and the WHO. Another important part of his work consists of liaising with European stakeholder associations and national health authorities.
Mr. Paulo Fonseca
Director-General | COOPERATIVE PLURAL+UDIFAR
Paulo Fonseca`s academical career started with a degree in pharmaceutical Sciences when he graduated from the University of Coimbra in 1992. During his studies he was the head-director assistant at the Farbeira Corporation. After finishing his degree in 1992 he became the technical-director and owner of “Bráulio Monteiro Pharmacy” in Manteigas until 1996. From 1997 till 1998 he was the technical director of Farcentro and became 1998 the CEO of Plural. In 2010 and 2012 he was elected as President of the Central Region of Pharmacists Society. Since 2020 he has been the chairman of the supervisory board of Bluephrama.
Mr. Markus Gampert
Partner | McKinsey& Company
Markus has extensive experience working on large-scale transformations and corporate strategy, as well as functional areas such as operations and commercial for the healthcare industry across Australia, Europe, and the United States. He serves clients across the healthcare, health- insurance, pharmaceutical, and logistics industries, as well as financial investors.
Markus’s recent projects include performance transformation at statutory health insurers and wholesalers, operating-model redesign for global pharmacos, and corporate-strategy and portfolio work for financial investors.
Before joining McKinsey in 2013, Markus was a researcher at the RWTH Aachen University, where his work focused on fluid dynamics and he published more than 20 scientific articles in peer-reviewed scientific journals.
Mr. Bernd Grabner
President | EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION (GIRP)
Mr Bernd Grabner is Member of the board of Jacoby GM Pharma and Vice-President of PHAGO, the Austrian Association of Pharmaceutical full-line Wholesalers. He has also been Member of the GIRP Board since June 2015.
Mr Grabner started his studies in law and business economics in Linz in 1993. While still studying, he worked in the family-owned wholesaling company, where he was in charge of a wide range of operational tasks.
Mr Grabner became member of the board of GM Pharma in 2003. Since the merger with Jacoby Pharmazeutika in July 2013, he has been member of the board of Jacoby GM Pharma and therein responsible for the division supplier relations, key account management for dispensing doctors and new business activities.
Ms. Tuula Lehto
Vice President Communications and Sustainability | Oriola
Tuula Lehto has been working at Oriola Group since October 2017 and she has been a member of the Oriola Management Team as of 1 July 2018. Before joining Oriola, she worked as Senior Consultant at communications agency Pohjoisranta Burson-Marsteller in 2011–2017. Earlier Lehto has been working in corporate communications at different organisations and roles in companies such as Finnish Slot Machine Association, Yara International, Kemira GrowHow Oyj and Veikkaus.
Mr. Doug Long
Vice President Industry Relations | IQVIA
Doug Long is Vice President of Industry Relations at IQVIA, the world’s largest pharmaceutical information company. Doug has been with IMS since 1989. His fundamental task is to help secure data for all existing and new databases supported by IQVIA, manage supplier, manufacturer & association relationships, and develop information for data partners. As direct consequence of his involvement in these areas, Doug has considerable experience with, a unique perspective on, the changing U.S. and global healthcare marketplace and pharmaceutical distribution.
Although well versed in the global pharmaceutical market, the heart of Doug’s Industry year review is that of trends and forecasts in the US. Doug is current on topics such as mergers and acquisitions, tiered co-pay, generics, biologics, PBM’s and other emerging channels, and is also an expert on the complex issue of patient privacy.
Doug was honored with the 2004 HDMA Nexus Award for lifetime achievement and received IMS’s prestigious Summit award in 2003.
Prior to IMS HEALTH, Doug was at Nielsen Market Research for sixteen years in various sales and marketing capacities. A native of Illinois, Doug received a BA degree from the DePaw University in Greencastle, Indiana, and an MBA in Management from Fairleigh Dickinson University in New Jersey.
Mr. João Almeida Lopes
President | Associação Portuguesa da Indústria Farmacêutica (APIFARMA)
João Almeida Lopes is Chairman of the Board of APIFARMA – Associação Portuguesa da Indústria Farmacêutica (Portuguese Pharmaceutical Industry Association) since 2007, and in 2014 became Vice-president of CIP - Confederação Empresarial de Portugal (Portuguese Business Confederation) where has streamlined the activity of the Strategic Health Council;
He has a graduation in Finance, from Instituto Superior de Economia and a diversified and strong professional experience. Between 1996 and 2011 he was Vice-Chairman and Chairman of the Board of IBET – Instituto de Biologia Experimental e Tecnológica (private non profit Biotechnology Research Organisation); Since 1990 he is General Director and Chairman of Grupo Medinfar (Portuguese Pharmaceutical Company) and, since 2008, Chairman of the Board of Genibet Biopharmaceuticals, SA (Biopharmaceutical Contract Manufacturing Organization).
Mr. Tony Mauro
President, Developed Markets | Viatris
Tony Mauro is president, Developed Markets, at Viatris, with responsibility for the performance of a $10.5 billion total revenue business and collaboration with its 5,500-member commercial team. Mauro oversees commercial functions in 35+ countries in North America and Europe, with a focus on executing dynamic, market-penetrating sales and marketing strategies to maintain and grow market leadership positions. He has a passion for building high-performing operating teams, driving excellence, expanding access and being a Partner of Choice to customers.
Prior to the creation of Viatris, Mauro served more than 25 years at Mylan, most recently as its chief commercial officer. He was responsible for leveraging the company’s diverse portfolio, pipeline and expansive commercial infrastructure to drive global growth across markets and channels. In 2016 he became a director of the Mylan Inc. board, a position he continues to hold.
Mauro previously held several roles of increasing responsibility at Mylan. He successfully led the company’s largest commercial business as president of North America. Before that position, he served as president of Mylan Pharmaceuticals Inc., the company's flagship generics division in the U.S.; chief operating officer of Mylan Pharmaceuticals ULC in Canada; vice president of North America Strategic Development; and vice president of North America Sales.
In addition, in 2012 and 2013 Mauro served as chairman of the board of directors of the U.S. Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers. He previously served two consecutive terms as vice chairman of the board for GPhA, which is now the Association for Accessible Medicines.
For several years Mauro also was a member of the visiting committee at West Virginia University's Graduate School of Business and Economics. He earned a bachelor's degree in business administration with a specialization in finance, and a master's degree in business administration, at WVU.
Mr. Magnus Meier
Global VP Wholesale Distribution | SAP
Magnus Meier is the Global Head of the Wholesale Distribution Industry Business Unit. Representing the industry inside and outside of SAP he works to provide industry thought leadership, portfolio direction and the global go to market strategy.
Magnus started with SAP in 1998 and acquired extensive cross industry, solution, services and support knowledge throughout his career. He has held a variety of positions internationally in SAP from consultant in Germany, to Manager of Industry Business Development teams in Japan and the U.S..
Magnus has a Master’s degree in economics from the Gerhard Mercator University in Duisburg with a special focus on East-Asia. He lives currently in the Chicago suburbs.
Mr. João Paulo Nascimento
Vice President | Associação Portuguesa de Medicamentos Genéricos e Biossimilares (APOGEN)
With more than 25 years of experience in the pharmaceutical industry, João Paulo has been working over the last 20 years in the generic industry assuming management responsibilities in the Marketing&Sales and Supply areas within Ratiopharm , Generis Farmacêutica , and Tolife SA as Country Manager. After the divestment of PENSA Pharma group to TOWA Pharmaceutical was appointed as Chief Commercial Officer of the Mediterranean countries.
He has been collaborating with APOGEN over the past 10 years within the technical commissions and has become, for the mandate 2021 2022, a member of APOGEN's Board, as Vice president.
He holds a degree in Marketing Management and post graduations in Management and Marketing.
Ms. Ema Paulino
President | Associação Nacional das Farmácias (ANF)
Ema Paulino completed her degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon in 2001, and a postgraduate degree in Community Pharmacy in 2003 from the same institution. She also holds a postgraduate degree in Leadership from the American Society of Health-System Pharmacists (2012), in Health Management from the Portuguese National School of Public Health (2014) and completed an Executive Program on Value Measurement for Health Care from the Harvard Business School in 2015.
Ema Paulino is a practising pharmacist at her own community pharmacy in Portugal. She was Director of Projects and Services at Holon from 2011 until 2018, and is currently General Manager at Ezfy, a company that engages community pharmacies in the implementation of Patient Support Programmes.
She is President of the Portuguese National Association of Pharmacies (ANF) and was a member of the National Board of the Portuguese Pharmaceutical Society (PPS) until June 2021. Previously, she was President of the South and Autonomous Region at PPS from 2013 until 2018, and a member of the Board of the National Association of Pharmacies between 2003 and 2012.
She represents ANF at various international groups and organisations such as the Pharmaceutical Group of the European Union (PGEU) and the International Pharmaceutical Federation (FIP).
Ema is Immediate past-Professional Secretary of FIP, and thus a member of its Executive Committee and Bureau until September 2021. Ema has previously been Chairperson and Project Coordinator of the Young Pharmacists' Group, a member of the FIP Programme Committee, and Secretary of the Community Pharmacy Section.
Ema is currently the Chairperson of the Pharmaceutical Care Network Europe (PCNE), and a member of the Board of the International Primary Care Respiratory Group (IPCRG).
Ema is a member of the Global Health Workforce Network’s Gender Equity Hub, an action-oriented community that aims to connect the dots across contexts and catapult progress in the gender-transformative approaches to health workforce, coordinated by the World Health Organization and Women in Global Health.
She was primary researcher in an international collaboration on identification of drug related problems in discharged patients, under the umbrella of the Stevenshof Institute for Pharmacy Practice Research (SIR) and European Society of Clinical Pharmacy (ESCP), The Netherlands, having won the Health Base Foundation Poster Award at the 30th ESCP Conference in Antwerp, Belgium, in 2001, for the poster and oral communication “Drug related problems among patients discharged from hospital”. Ema also conducted research on facilitators of practice change in community pharmacy.
Ema’s leadership positions include Secretary General and Permanent Officer in The Netherlands for the European Pharmaceutical Students’ Association (EPSA) 2000-2001, President of the Portuguese Pharmacy Students’ Association (APEF) 1999-2000, Chairperson of Health Information, Promotion and Education Working Group of the local Students’ Association 1998-2000, Member of the National Department of Health Information, Promotion and Education of APEF 1998-1999, Member of the Representative Assembly of the Faculty of Pharmacy of Lisbon 1997-2000, and Vice –President of the High school Students’ Association 1992-1994.
Ms. Saila Rinne
Head of Sector, DG CONNECT -Directorate-General for Communications Networks, Content and Technology, Unit H3 –eHealth, Well-being & Ageing | European Commission
Saila Rinne is the Head of Sector for policy in the unit “eHealth, Well-Being and Ageing” at the Directorate-General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission. Her team collaborates closely with other services of the Commission and various stakeholders to support innovative digital health technologies, services and products that foster high quality and efficient health and care delivery as well as citizen empowerment in managing their own health. Saila has had a long career in the Commission and has previously worked on the research and innovation activities of Data Policy and Innovation and as a translator and terminologist in DG Translation of the Commission.
Mr. Torsten Roos
General Manager | INSIGHT Health
Torsten Roos is General Manager at INSIGHT Health, the German based information and big data provider. He is member of the executive board and responsible for the expansion of international data panels, strategic alliances with data suppliers/partners and the development of new data strategies.
Before taking over this responsibility, he joined the former NDC Health in 2000 and implemented the company`s product portfolio for wholesalers and pharmacies. Till 2008 he served INSIGHT Health as director data source in Germany. During the international expansion of INSIGHT Health in the last years, Torsten established the company as strategic partner for wholesaler, retailers and pharmaceutical traders in Europe and managed the expansion in new data panels in several European countries.
Due to his functions and career, Torsten is an expert in Health Care Data and digital data contents. Torsten studied social science at Justus-Liebig-University, Gießen and University RheinMain, Wiesbaden and holds an MBA of the FOM University, Essen.
Mr. Rui Santos Ivo
President | INFARMED Portuguese Medicines Agency
Rui Santos Ivo is currently Vice-President of INFARMED – National Authority of Medicines and Health Products, I.P., since January 2016. Member of the Management Board of the EMA since March 2016. Member of the Executive Board of EUnetHTA- the European Network for Health Technology Assessment, since 2016. Vice-chair of the Valletta Permanent Technical Committee/Valletta Declaration, since 2016. He is also an Invited Assistant Professor of Medicines Regulation, at the University of Lisbon Faculty of Pharmacy. He is an external elected member of the General Council of the University of Coimbra, since 2017. Previously he was President (2014/2016) and Vice-President (2011/2014) of the Central Administration of the Health System (ACSS,IP) at the Ministry of Health, in Portugal. He was Coordinator of the Hospital Reform Project Team (2012/2015) and chaired the Governance College for the Public Health Subsystems (2015/2016). R. Santos Ivo initiated his professional career as a hospital pharmacist at Hospital de Egas Moniz, in Lisbon. In 1993 he joined INFARMED, where he held various responsibilities, namely vice-president (1994-2000) and President (2002-2005). In 2000-2002 he worked as Administrator at the Directorate of the European Medicines Agency (EMA), in London, and in 2006-2008 he worked for the European Commission as Administrator at the Pharmaceuticals Unit, Directorate General for Enterprise and Industry, in Brussels. He was a member of the Management Board of the EMA (2002/2005) and the first Chairman of the European Union Heads of Medicines Agencies Management Group (2004-2005). In 2008-2011 he was Executive Director of the Portuguese Association of the Pharmaceutical Industry (APIFARMA). R. Santos Ivo graduated in Pharmaceutical Sciences by the University of Lisbon in 1987. Specialist in Hospital Pharmacy (1992) and Pharmaceutical Regulation by the Portuguese Pharmaceutical Society (1997). Post graduate education on Health Law and Pharmaceutical Legislation (University of Lisbon Faculty of Law and National School of Public Health), Pharmaceutical Medicine (University of Basel), Regulation (London School of Economics and Political Science) and Health Management (Portuguese Catholic University (2000) and AESE (2015). Almofariz Prize, Personality of the Year in the Pharmaceutical Sector (2004), European Correspondent Member, Académie Nationale de Pharmacie, France (2014) and Medal (gold) for distinguished Services, Ministry of Health (2015).
Mr. Margaritis Schinas
Vice-President for Promoting our European Way of Life | European Commission
Margaritis Schinas started his professional career path as a member of the cabinet to Commissioners Matutes and Oreja in 1993. In 1999 he became Deputy Head of Cabinet to Commission Vice-President Loyola de Palacio, where he was responsible for Transport, Energy and Relations with the European Parliament. Under Commissioner Markos Kyprianou he became Head of Cabinet for Health and Consumer Protection in 2004, before holding a term as Member of the Europe Parliament from 2007 to 2009. In the period from 2010 to 2013 he held the position of Deputy Head of the Bureau of the European Policy Advisers within the European Commission and became the Resident Director in Athens as Head of Greece Operations afterwards. In 2014 Margaritis Schinas was voted as Chief Spokesperson of the EU Commission, which was followed by his position as Deputy Director-General for Communication. Since 2019 he has been the EU Commission`s Vice President for Promoting our European Way of Life aiming to create a European Security Union by ensuring coherence of the external and internal dimensions of security.
Mr. Sven Seidel
Chief Executive Officer, | PHOENIX Group
Sven Seidel is Chief Executive Officer for PHOENIX group, the leading pharmaceutical wholesaler and retail pharmacy operator in Europe with operations in 27 countries. In this role, he is driving the transformation of the 30 bEUR company towards an integrated healthcare provider.
Sven Seidel has over 10 years of C-Suite leadership experience in leading globally operating companies, having held executive board positions on three continents, and more than 10 years of leadership experience in global business consulting. Throughout his career, he has gained a reputation as an expert for consumer products and consumer health, with a strong focus on omni-channel commerce and digital transformation.
Dr. Diogo Serras Lopes
Secretary of State of Health | Government of Portugal
Diogo Serras Lopes was born in Lisbon, in 1975.
With a degree in Economics by the Business School of Universidade Nova de Lisboa, he also attended the Masters in Political Sciences at the Instituto Superior das Ciências do Trabalho e da Empresa – Instituto Universitário de Lisboa. He’s also, since 2005, CFA Charterholder (CFA Institute). He began his professional path in 1998, as a journalist at the Economia Pura Magazine, and, from 1999 to 2014, also worked in asset management in a series of private institutions such as MC Fundos, Santander Asset Management and Banco Best.
From May 2014 to November 2015, he worked in the Regulatory Policy and International Affairs Department at Comissão do Mercado de Valores Mobiliários (Portuguese Securities Market Commission).
From December 2015 to August 2017, he was also adviser to the Secretary of State Assistant to the Prime Minister and from August 2017 to April 2019, he was appointed adviser for economical affairs to the Prime-Minister, in the first Government of Prime Minister Costa.
From April 2019 to September 2020, he was Vice President at the Central Administration of the Health System (ACSS).
Mr. Per Troein
Vice President Strategic Partners | IQVIA
Per Troein has been with IQVIA for 19 years and is responsible for the relationship with suppliers and associations. The dispensing and distribution environment is very dynamic. Pricing of pharmaceutical is as complicated. He also has deep insight around generics and biosimilars and how they are handled in different markets. One of IQVIA’ priorities is to have the best understanding of those dynamics to secure the most appropriate data, to be the best partner with the different data partners, and to be able to support the industry and also when appropriate governments. He is a well know speaker in the field of distribution trends and pricing and is very active in consulting projects in the area.
Prior to joining IMS, Per worked 13 years for Pharmacia in US and Europe. His last 6 years were spent in strategic development as a VP including several major mergers and acquisitions.
He holds an MSc in engineering from Lund’s Institute of Technology and an MBA from INSEAD.